These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4977407)

  • 21. Post-exposure serological and bacteriological responses of water buffalo (Bubalus bubalis) to Brucella abortus biovar 1 following vaccination with Brucella abortus strain RB51.
    Diptee MD; Asgarali Z; Campbell M; Fosgate G; Adesiyun AA
    Rev Sci Tech; 2007 Dec; 26(3):669-78. PubMed ID: 18293615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of antibodies active in the Rose Bengal plate test.
    Corbel MJ
    Vet Rec; 1972 Apr; 90(17):484-5. PubMed ID: 4625090
    [No Abstract]   [Full Text] [Related]  

  • 23. Biochemical and biological properties of soluble protein preparations from Brucella abortus.
    Tabatabai LB; Deyoe BL
    Dev Biol Stand; 1984; 56():199-211. PubMed ID: 6436094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brucella abortus strain RB51 vaccine: its advantages and risks.
    Kahler SC
    J Am Vet Med Assoc; 1998 Jul; 213(1):12, 22. PubMed ID: 9656011
    [No Abstract]   [Full Text] [Related]  

  • 25. Serologic response of pigs to experimental infection with Yersinia enterocolitica serotype O9 and Brucella abortus.
    Mittal KR; Tizard IR
    Am J Vet Res; 1981 Mar; 42(3):443-6. PubMed ID: 6791534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Avian brucellosis: a case report of natural transmission from cattle.
    Angus RD; Brown GM; Gue CS
    Am J Vet Res; 1971 Oct; 32(10):1609-12. PubMed ID: 5000500
    [No Abstract]   [Full Text] [Related]  

  • 27. Selection analysis of populations of vaccine strains of Brucella.
    Vershilova PA; Ostrovskaya NN; Grekova NA
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(1):34-46. PubMed ID: 4958780
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunologic reorganization of persons vaccinated cutaneously with vaccinal strains of Br. abortus No. 19 and 104-M].
    Aubakirov SA; Abdullina GA; Shmuter MF; Uzbekova BR; Sosunova AN
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):22-6. PubMed ID: 4978569
    [No Abstract]   [Full Text] [Related]  

  • 29. Factors influencing biometric potency assays of brucella allergens in guinea-pigs.
    Jones LM; Berman DT; Diaz R
    Br J Exp Pathol; 1973 Aug; 54(4):368-79. PubMed ID: 4199238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brucella melitensis B115-based complement fixation test to detect antibodies induced by Brucella rough strains.
    Adone R; Francia M; Ciuchini F
    J Appl Microbiol; 2008 Aug; 105(2):567-74. PubMed ID: 18355234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoproteomic characterization of Brucella abortus 1119-3 preparations used for the serodiagnosis of Brucella infections.
    Al Dahouk S; Nöckler K; Scholz HC; Tomaso H; Bogumil R; Neubauer H
    J Immunol Methods; 2006 Feb; 309(1-2):34-47. PubMed ID: 16427071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a second generation competitive enzyme immunoassay (CELISA) for the diagnosis of brucellosis in various species of domestic animals.
    Nielsen K; Smith P; Yu WL; Elmgren C; Halbert G; Nicoletti P; Perez B; Conde S; Samartino L; Nicola A; Bermudez R; Renteria T
    Vet Immunol Immunopathol; 2008 Oct; 125(3-4):246-50. PubMed ID: 18771805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51.
    Elzer PH; Enright FM; Colby L; Hagius SD; Walker JV; Fatemi MB; Kopec JD; Beal VC; Schurig GG
    Am J Vet Res; 1998 Dec; 59(12):1575-8. PubMed ID: 9858409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The isolation of Brucella abortus from milk. I. Biological examination (guinea-pig inoculation).
    Farrell ID; Robertson L
    Mon Bull Minist Health Public Health Lab Serv; 1967; 26():52-9. PubMed ID: 4962743
    [No Abstract]   [Full Text] [Related]  

  • 35. [Detection of antibodies in serum in brucellosis by the indirect immunofluorescence method].
    Chernysheva MI; Aslanian RG; Shcherbak IuF; Mnatsakanian AG
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Aug; 45(8):62-5. PubMed ID: 4978503
    [No Abstract]   [Full Text] [Related]  

  • 36. Incidence and seasonal prevalence among an occupationally-exposed population to brucellosis.
    Alausa OK
    Trop Geogr Med; 1980 Mar; 32(1):12-5. PubMed ID: 6771907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the pathogenicity of nonstable Brucella L-forms and their revertants.
    Grekova NA; Tolmacheva TA; Vershilova PA
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):129-34. PubMed ID: 119809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Enzyme immunoassay to demonstrate antibodies against Brucella abortus in the sera of cattle].
    Herrmann H; Dedek J
    Arch Exp Veterinarmed; 1982; 36(6):871-80. PubMed ID: 6820266
    [No Abstract]   [Full Text] [Related]  

  • 39. A study of delayed hypersensitivity and desensitization in guinea pigs after Brucella infection.
    Lu SL
    Dev Biol Stand; 1984; 56():317-21. PubMed ID: 6436098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
    Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.